176 related articles for article (PubMed ID: 38375992)
1. Coinfections in human papillomavirus associated cancers and prophylactic recommendations.
Ashok G; Basu S; Priyamvada P; Anbarasu A; Chintala S; Ramaiah S
Rev Med Virol; 2024 Mar; 34(2):e2524. PubMed ID: 38375992
[TBL] [Abstract][Full Text] [Related]
2. In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers.
Lehtinen M; Gray P; Louvanto K; Vänskä S
Expert Rev Vaccines; 2022 Jun; 21(6):735-738. PubMed ID: 35404177
[No Abstract] [Full Text] [Related]
3. HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women.
Hernández-Silva CD; Ramírez de Arellano A; Pereira-Suárez AL; Ramírez-López IG
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543693
[TBL] [Abstract][Full Text] [Related]
4. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
Han JJ; Tarney CM; Song J
Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccines versus cervical cancer screening.
Stanley M
Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):388-94. PubMed ID: 18538554
[TBL] [Abstract][Full Text] [Related]
7. Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination.
Dillner J; Arbyn M; Dillner L
Clin Exp Immunol; 2007 May; 148(2):199-207. PubMed ID: 17437418
[TBL] [Abstract][Full Text] [Related]
8. HPV-Related Cancers: A Growing Threat to U.S. Military Health and Readiness.
Seay J; Matsuno R; Buechel J; Tannenbaum K; Wells N
Mil Med; 2022 May; 187(5-6):149-154. PubMed ID: 34697641
[TBL] [Abstract][Full Text] [Related]
9. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
Poljak M; Šterbenc A; Lunar MM
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
[TBL] [Abstract][Full Text] [Related]
10. [Human papillomavirus infection and vaccination].
He ZH; Kou ZQ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):106-112. PubMed ID: 29334719
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of prophylactic HPV vaccines against cervical abnormalities and HPV infection in Japan: The J-HERS 2021 multicenter study.
Saeki Y; Saito M; Irie T; Itoh F; Enatsu A; Komura H; Fujii M; Fujii R; Hidaka N; Maehama T; Shirasu N; Waseda T; Shibata T; Takada E; Mibe K; Sakamoto J; Yamada S; Takakura M; Sasagawa T
J Med Virol; 2024 Feb; 96(2):e29413. PubMed ID: 38314927
[TBL] [Abstract][Full Text] [Related]
12. Role of human papillomavirus (HPV) in cancers.
Khan A
S Afr Med J; 2023 Oct; 113(10):10. PubMed ID: 37881906
[No Abstract] [Full Text] [Related]
13. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer in Ethiopia: a review of the literature.
Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
[TBL] [Abstract][Full Text] [Related]
15. On the Elimination of Infections Related to Oncogenic Human Papillomavirus: An Approach Using a Computational Network Model.
Muñoz-Quiles C; Díez-Domingo J; Acedo L; Sánchez-Alonso V; Villanueva RJ
Viruses; 2021 May; 13(5):. PubMed ID: 34068358
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China.
Chen M; Li C; Cui Q; Zhou C; Chen P; Yao S
Eur J Obstet Gynecol Reprod Biol; 2023 Jul; 286():10-15. PubMed ID: 37159990
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
Mboumba Bouassa RS; Prazuck T; Lethu T; Jenabian MA; Meye JF; Bélec L
Expert Rev Anti Infect Ther; 2017 Jun; 15(6):613-627. PubMed ID: 28440679
[TBL] [Abstract][Full Text] [Related]
18. HPV Update: Vaccination, Screening, and Associated Disease.
McNamara M; Batur P; Walsh JME; Johnson KM
J Gen Intern Med; 2016 Nov; 31(11):1360-1366. PubMed ID: 27184752
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus: current status and issues of vaccination.
Malik H; Khan FH; Ahsan H
Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
[TBL] [Abstract][Full Text] [Related]
20. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
Michelow P; Firnhaber C
Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
[No Abstract] [Full Text] [Related]
[Next] [New Search]